Universe Pharmaceuticals (UPC) Enterprise Value (2020 - 2025)
Universe Pharmaceuticals' Enterprise Value history spans 6 years, with the latest figure at -$70.2 million for Q3 2025.
- On a quarterly basis, Enterprise Value rose 99.77% to -$70.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$70.2 million, a 99.77% increase, with the full-year FY2025 number at -$70.2 million, up 99.77% from a year prior.
- Enterprise Value hit -$70.2 million in Q3 2025 for Universe Pharmaceuticals, up from -$30.9 billion in the prior quarter.
- Over the last five years, Enterprise Value for UPC hit a ceiling of -$7.8 million in Q1 2024 and a floor of -$30.9 billion in Q3 2024.
- Historically, Enterprise Value has averaged -$5.3 billion across 5 years, with a median of -$46.3 million in 2022.
- Biggest five-year swings in Enterprise Value: plummeted 26155.92% in 2022 and later skyrocketed 99.77% in 2025.
- Tracing UPC's Enterprise Value over 5 years: stood at -$21.8 million in 2021, then plummeted by 26155.92% to -$5.7 billion in 2022, then rose by 7.65% to -$5.3 billion in 2023, then crashed by 484.03% to -$30.9 billion in 2024, then skyrocketed by 99.77% to -$70.2 million in 2025.
- Business Quant data shows Enterprise Value for UPC at -$70.2 million in Q3 2025, -$30.9 billion in Q3 2024, and -$7.8 million in Q1 2024.